This article explains, in educational terms, embolic protection — how the technology works and where it fits. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing.
Embolic Protection
Embolic protection devices capture plaque or clot fragments dislodged during an intervention so they do not travel downstream. They are frequently used alongside atherectomy or in lesions with a high embolic risk. INVAMED's Guardian protection device is designed for this distal-capture role. Use is guided by lesion morphology and clinician preference.
Design and Technical Notes
INVAMED's PAD portfolio spans access, plaque modification, angioplasty, drug delivery, stenting, and embolic protection. Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting. Access sheath sizing should match the planned devices to limit access-site complications.
Key Considerations
- INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
- Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting.
- Access sheath sizing should match the planned devices to limit access-site complications.
Frequently Asked Questions
Does INVAMED make a drug-coated balloon?
Yes. The Extender paclitaxel drug-coated balloon is INVAMED's peripheral drug-delivery balloon.
Is a stent always needed in PAD?
No. Many lesions are treated with angioplasty or drug-coated balloons alone; a stent is added when the vessel recoils or dissects.
Are these devices CE marked?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Access sheath sizing should match the planned devices to limit access-site complications. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes. Use is guided by lesion morphology and clinician preference. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Drug dose and balloon sizing follow the device specifications and lesion characteristics. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. Manufacturer figures reflect studied device performance, not guaranteed outcomes. Appropriate access selection helps reduce access-site complications. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Covered stent grafts can be used to exclude certain lesions or manage complications. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels. INVAMED's TemREN atherectomy system is positioned for peripheral plaque modification.
Related on INVAMED
- Peripheral Arterial Disease (PAD) — product category
- Atherectomy or Balloon angioplasty? A Technical Comparison
- Atlas Endovascular Peripheral Stent Graft: Features, Specifications and Clinical Role
- A Clinical Introduction to Atherectomy
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.